Jump to content
RemedySpot.com

drug companies

Rate this topic


Guest guest

Recommended Posts

Athena Diagnostics withdraws plans for IPO

Thu Oct 7, 2004 04:17 PM ET WASHINGTON, Oct 7 (Reuters) - Neurological testing developer Athena Diagnostics Inc. canceled its plans for a $120 million initial public stock offering, according to a regulatory filing on Thursday. The Worcester, Massachusetts-based company gave no reason for canceling the offering, which was to be underwritten by UBS Warburg, according to filings with the U.S. Securities and Exchange Commission. Might this be because of the bad news lately involving the pharmaceutical companies?

Regards,

Tom

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...